Ahmed Talat B, Eggesbø Merete, Criswell Rachel, Demmelmair Hans, Totzauer Martina, Koletzko Berthold
Division of Metabolic and Nutritional Medicine, Department of Paediatrics, Dr. von Hauner Children's Hospital, LMU University Hospital, Munich, Germany; German Center for Child and Adolescent Health, site Munich, Germany.
Department of Paraclinical Sciences, Norwegian University of Life Sciences, Norway.
J Nutr. 2025 Jun;155(6):1818-1827. doi: 10.1016/j.tjnut.2025.04.009. Epub 2025 Apr 12.
Human milk fat quality depends on its fatty acid (FA) and phospholipid (PL) composition. There is clear evidence that maternal diet influences human milk FA composition. However, the scientific literature concerning associations between prepregnancy body mass index (pBMI) and milk FA and PL composition remains inconclusive.
This observational study aimed to identify the associations between maternal pBMI and the milk FA and choline-containing PL species composition, considering study confounders, including fish intake as a proxy for n3 long-chain polyunsaturated FA (n3-LCPUFA).
We analyzed total FA and choline-containing PL-classes (lysophosphatidylcholine, phosphatidylcholine, and sphingomyelin) in 628 milk samples from the Norwegian Human Milk Study birth-cohort using gas chromatography and flow-injection mass spectrometry, respectively. Multiple regression analysis assessed the relationship between pBMI and milk lipid metabolites (%FA, %PL) (reported as β = standardized regression coefficient with adjusted P value < 0.0005, B(95% confidence interval [CI]) = unstandardized coefficient with 95% CI).
Maternal pBMI showed significant association (P < 0.0005) with n3-LCPUFA [β = -0.138, B(95% CI) = -0.010 (-0.015, -0.005)], n6/n3LCPUFA ratio [β = 0.170, B(95% CI) = 0.020(0.012, 0.028)], monounsaturated FA [β = 0.207, B(95% CI) = 0.128(0.076, 0.180)], and corresponding PL species [%LysoPC16:1, β = 0.171, B(95% CI) = 0.001(0.001,0.002), %LysoPC18:1, β = 0.155, B(95%CI) = 0.005 (0.002,0.007)] adjusted with the study covariates. The percentages of variance explained by pBMI were 40% for the n6/n3 LCPUFA ratio, 34% for n3-LCPUFA, and 10% for monounsaturated FA. Conversely, analyses revealed no significant associations between pBMI and choline-containing PL classes.
Biological factors likely increased stearoyl-CoA desaturase activity, lower lipoprotein lipase activity, and a compensatory higher contribution of nonesterified FA from adipose tissue in mothers with pBMI ≥30 could potentially lead to the observed outcomes. Metabolic differences regarding BMI variances may influence the FA availability for mammary gland triglyceride and PL synthesis. Therefore, in addition to dietary intake, maintaining a healthy maternal pBMI may improve the nutritional quality of human milk, ultimately supporting infants' development.
人乳脂肪质量取决于其脂肪酸(FA)和磷脂(PL)组成。有明确证据表明,母亲的饮食会影响人乳脂肪酸组成。然而,关于孕前体重指数(pBMI)与乳脂肪酸和磷脂组成之间关联的科学文献尚无定论。
本观察性研究旨在确定母亲pBMI与乳脂肪酸及含胆碱磷脂种类组成之间的关联,同时考虑研究混杂因素,包括将鱼类摄入量作为n-3长链多不饱和脂肪酸(n-3-LCPUFA)的替代指标。
我们分别使用气相色谱法和流动注射质谱法分析了挪威人乳研究队列中628份母乳样本中的总脂肪酸和含胆碱磷脂类别(溶血磷脂酰胆碱、磷脂酰胆碱和鞘磷脂)。多元回归分析评估了pBMI与乳脂质代谢物(%脂肪酸、%磷脂)之间的关系(报告为β=标准化回归系数,校正P值<0.0005,B(95%置信区间[CI])=非标准化系数及95%CI)。
经研究协变量校正后,母亲pBMI与n-3-LCPUFA [β=-0.138,B(95%CI)=-0.010(-0.015,-0.005)]、n6/n3LCPUFA比值[β=0.170,B(95%CI)=0. 020(0.012,0.028)]、单不饱和脂肪酸[β=0.207,B(95%CI)=0.128(0.076,0.180)]以及相应的磷脂种类[ %溶血磷脂酰胆碱16:1,β=0.171,B(95%CI)=0.001(0.001,0.002),%溶血磷脂酰胆碱18:1,β=0.155,B(95%CI)=0.005(0.002,0.007)]存在显著关联。pBMI解释的方差百分比,n6/n3 LCPUFA比值为40%,n-3-LCPUFA为34%,单不饱和脂肪酸为10%。相反,分析显示pBMI与含胆碱磷脂类别之间无显著关联。
生物学因素可能会增加硬脂酰辅酶A去饱和酶活性,降低脂蛋白脂肪酶活性,并且在pBMI≥30的母亲中,脂肪组织中非酯化脂肪酸的代偿性更高贡献可能会导致观察到的结果。BMI差异导致的代谢差异可能会影响乳腺甘油三酯和磷脂合成中脂肪酸的可用性。因此,除饮食摄入外,维持健康的母亲pBMI可能会改善人乳的营养质量,最终支持婴儿发育。